Meropenem serum concentrations in intensive care patients: A retrospective analysis

Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F20%3AA22029OR" target="_blank" >RIV/61988987:17110/20:A22029OR - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00843989:_____/20:E0108744
Výsledek na webu
<a href="https://www.researchgate.net/publication/350203691_Meropenem_serum_concentrations_in_intensive_care_patients_a_retrospective_analysis" target="_blank" >https://www.researchgate.net/publication/350203691_Meropenem_serum_concentrations_in_intensive_care_patients_a_retrospective_analysis</a>
DOI - Digital Object Identifier
—

Jazyk výsledku
angličtina
Název v původním jazyce
Meropenem serum concentrations in intensive care patients: A retrospective analysis
Popis výsledku v původním jazyce
To determine whether currently used meropenem dosages in our hospital provide adequate serum concentrations. Methods: Trough blood samples taken during the first meropenem concentration monitoring were included. For the evaluation of achievement of the pharmacokinetic/ pharmacodynamic (PK/PD) target, MIC of the pathogens defined by the European Committee on Antimicrobial Susceptibility testing was selected. Results: Eighty three patients were enrolled.
Název v anglickém jazyce
Meropenem serum concentrations in intensive care patients: A retrospective analysis
Popis výsledku anglicky
To determine whether currently used meropenem dosages in our hospital provide adequate serum concentrations. Methods: Trough blood samples taken during the first meropenem concentration monitoring were included. For the evaluation of achievement of the pharmacokinetic/ pharmacodynamic (PK/PD) target, MIC of the pathogens defined by the European Committee on Antimicrobial Susceptibility testing was selected. Results: Eighty three patients were enrolled.

Rok uplatnění
2020
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Podobné výsledky(10)